Crossover design in tamoxifen bioequivalence: a borderline situation.
A
A
Marzo
D018931:Antineoplastic Agents, Hormonal / Q000378:metabolism / Q000493:pharmacokinetics*; D019540:Area Under Curve; D018592:Cross-Over Studies; D005260:Female; D006801:Humans; D008657:Metabolic Clearance Rate; D012107:Research Design; D013629:Tamoxifen / Q000378:metabolism / Q000493:pharmacokinetics*; D013810:Therapeutic Equivalency
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen